Education/CredentialsPhD: Tottori University Faculty of Medicine, Department of Brain and Neurosciences MD: Tottori University Faculty of Medicine Contact Information Email ikegamse@ucmail.uc.edu Peer Reviewed Publications Ikegami S, Benirschke R, Flanagan T, Tanna N, Klein T, Elue R, Debosz P, Mallek J, Wright G, Guariglia P, Kang J, Gniadek TJ. 08-24-2020. Persistence of SARS-CoV-2 Nasopharyngeal Swab PCR Positivity in COVID-19 Convalescent Plasma Donors Transfusion, , Kam KL, Appin C, Mao Q, Ikegami S, Lukas RV, Nikiforova NM, Roy S, Brat D, Horbinski MC 07-01-2020. Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas? J Neuropathol Exp Neurol, , Muller C, Yamada A, Ikegami S, Haider H, Komaki Y, Komaki F, Micic D, Sakuraba A 06-02-2021. Risk of colorectal cancer in serrated polyposis syndrome: A systematic review and meta-analysis Clinical Gastroenterology and Hepatology, , Ikegami S, Benirschke R, Fakhrai-Rad H, Motamedi M, Hockett R, David S, Lee HK, Kang J, Gniadek TJ 04-28-2021. Target specific serologic analysis of COVID-19 convalescent plasma PLoS One, , Klein T, Elue R, Ikegami S, Mikkelson C, Wright G, Mallek J, Kang J, Sullivan DJ, Gniadek TJ 02-10-2021. Rapidly Establishing a Hospital-Based Convalescent Plasma Collection Center with the Alyx Apheresis Collection Device Academic Pathology, , Shimizu S, Kadowaki M, Yoshioka H, Kambe A, Watanabe T, Kinyamu HK, Eling TE. 01-25-2013. Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells. Biochemical and Biophysical Research Communications, , Abstract Publications Ikegami K, Secchia S, Almakki O, Stutzman A, Ikegami S, Ayres N, Liu SY, Lieb JD, Moskowitz IP 10-27-2020. Nuclear lamins at enhancers: a new hypothesis for laminopathies Circulation Research, , Kam KL, Appin C, Mao Q, Ikegami S, Nikiforova NM, Roy S, Brat D, Horbinski MC 06-01-2019. The Accuracy of Relying on Next Generation Sequencing (NGS) Alone to Diagnose Infiltrating Gliomas J Neuropathol Exp Neurol, 78 6, 520-579Ikegami. S, Lee JP 03-15-2022. Molecular Therapeutic Target Profiles of High-Grade Ovarian Carcinomas: An Institutional Experience Modern Pathology, 102 , 760Kam KL, Appin C, Mao Q, Ikegami S, Roy S, Brat D, Nikiforova NM, Horbinski MC 03-02-2019. The Feasibility of Relying on Next Generation Sequencing to Diagnose Gliomas. Modern Pathology, 32 2, 1-39
Peer Reviewed Publications Ikegami S, Benirschke R, Flanagan T, Tanna N, Klein T, Elue R, Debosz P, Mallek J, Wright G, Guariglia P, Kang J, Gniadek TJ. 08-24-2020. Persistence of SARS-CoV-2 Nasopharyngeal Swab PCR Positivity in COVID-19 Convalescent Plasma Donors Transfusion, , Kam KL, Appin C, Mao Q, Ikegami S, Lukas RV, Nikiforova NM, Roy S, Brat D, Horbinski MC 07-01-2020. Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas? J Neuropathol Exp Neurol, , Muller C, Yamada A, Ikegami S, Haider H, Komaki Y, Komaki F, Micic D, Sakuraba A 06-02-2021. Risk of colorectal cancer in serrated polyposis syndrome: A systematic review and meta-analysis Clinical Gastroenterology and Hepatology, , Ikegami S, Benirschke R, Fakhrai-Rad H, Motamedi M, Hockett R, David S, Lee HK, Kang J, Gniadek TJ 04-28-2021. Target specific serologic analysis of COVID-19 convalescent plasma PLoS One, , Klein T, Elue R, Ikegami S, Mikkelson C, Wright G, Mallek J, Kang J, Sullivan DJ, Gniadek TJ 02-10-2021. Rapidly Establishing a Hospital-Based Convalescent Plasma Collection Center with the Alyx Apheresis Collection Device Academic Pathology, , Shimizu S, Kadowaki M, Yoshioka H, Kambe A, Watanabe T, Kinyamu HK, Eling TE. 01-25-2013. Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells. Biochemical and Biophysical Research Communications, ,
Ikegami S, Benirschke R, Flanagan T, Tanna N, Klein T, Elue R, Debosz P, Mallek J, Wright G, Guariglia P, Kang J, Gniadek TJ. 08-24-2020. Persistence of SARS-CoV-2 Nasopharyngeal Swab PCR Positivity in COVID-19 Convalescent Plasma Donors Transfusion, , Kam KL, Appin C, Mao Q, Ikegami S, Lukas RV, Nikiforova NM, Roy S, Brat D, Horbinski MC 07-01-2020. Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas? J Neuropathol Exp Neurol, , Muller C, Yamada A, Ikegami S, Haider H, Komaki Y, Komaki F, Micic D, Sakuraba A 06-02-2021. Risk of colorectal cancer in serrated polyposis syndrome: A systematic review and meta-analysis Clinical Gastroenterology and Hepatology, , Ikegami S, Benirschke R, Fakhrai-Rad H, Motamedi M, Hockett R, David S, Lee HK, Kang J, Gniadek TJ 04-28-2021. Target specific serologic analysis of COVID-19 convalescent plasma PLoS One, , Klein T, Elue R, Ikegami S, Mikkelson C, Wright G, Mallek J, Kang J, Sullivan DJ, Gniadek TJ 02-10-2021. Rapidly Establishing a Hospital-Based Convalescent Plasma Collection Center with the Alyx Apheresis Collection Device Academic Pathology, , Shimizu S, Kadowaki M, Yoshioka H, Kambe A, Watanabe T, Kinyamu HK, Eling TE. 01-25-2013. Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells. Biochemical and Biophysical Research Communications, ,
Abstract Publications Ikegami K, Secchia S, Almakki O, Stutzman A, Ikegami S, Ayres N, Liu SY, Lieb JD, Moskowitz IP 10-27-2020. Nuclear lamins at enhancers: a new hypothesis for laminopathies Circulation Research, , Kam KL, Appin C, Mao Q, Ikegami S, Nikiforova NM, Roy S, Brat D, Horbinski MC 06-01-2019. The Accuracy of Relying on Next Generation Sequencing (NGS) Alone to Diagnose Infiltrating Gliomas J Neuropathol Exp Neurol, 78 6, 520-579Ikegami. S, Lee JP 03-15-2022. Molecular Therapeutic Target Profiles of High-Grade Ovarian Carcinomas: An Institutional Experience Modern Pathology, 102 , 760Kam KL, Appin C, Mao Q, Ikegami S, Roy S, Brat D, Nikiforova NM, Horbinski MC 03-02-2019. The Feasibility of Relying on Next Generation Sequencing to Diagnose Gliomas. Modern Pathology, 32 2, 1-39
Ikegami K, Secchia S, Almakki O, Stutzman A, Ikegami S, Ayres N, Liu SY, Lieb JD, Moskowitz IP 10-27-2020. Nuclear lamins at enhancers: a new hypothesis for laminopathies Circulation Research, , Kam KL, Appin C, Mao Q, Ikegami S, Nikiforova NM, Roy S, Brat D, Horbinski MC 06-01-2019. The Accuracy of Relying on Next Generation Sequencing (NGS) Alone to Diagnose Infiltrating Gliomas J Neuropathol Exp Neurol, 78 6, 520-579Ikegami. S, Lee JP 03-15-2022. Molecular Therapeutic Target Profiles of High-Grade Ovarian Carcinomas: An Institutional Experience Modern Pathology, 102 , 760Kam KL, Appin C, Mao Q, Ikegami S, Roy S, Brat D, Nikiforova NM, Horbinski MC 03-02-2019. The Feasibility of Relying on Next Generation Sequencing to Diagnose Gliomas. Modern Pathology, 32 2, 1-39